0 01/04/2025 31/03/2026 2026-03-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2025-04-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP NI710682 2025-04-01 2026-03-31 NI710682 2026-03-31 NI710682 2025-03-31 NI710682 2024-04-01 2025-03-31 NI710682 2025-03-31 NI710682 2024-03-31 NI710682 bus:RegisteredOffice 2025-04-01 2026-03-31 NI710682 bus:Director1 2025-04-01 2026-03-31 NI710682 bus:Director2 2025-04-01 2026-03-31 NI710682 bus:Director3 2025-04-01 2026-03-31 NI710682 bus:Director4 2025-04-01 2026-03-31 NI710682 bus:Director5 2025-04-01 2026-03-31 NI710682 core:WithinOneYear 2026-03-31 NI710682 core:WithinOneYear 2025-03-31 NI710682 core:ShareCapital 2026-03-31 NI710682 core:ShareCapital 2025-03-31 NI710682 core:RetainedEarningsAccumulatedLosses 2026-03-31 NI710682 core:RetainedEarningsAccumulatedLosses 2025-03-31 NI710682 bus:SmallEntities 2025-04-01 2026-03-31 NI710682 bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 NI710682 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 NI710682 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 NI710682 bus:FullAccounts 2025-04-01 2026-03-31
Company registration number: NI710682
BW Ireland Ltd
Unaudited filleted financial statements
31 March 2026
BW Ireland Ltd
Contents
Directors and other information
Statement of financial position
Notes to the financial statements
BW Ireland Ltd
Directors and other information

| Directors | Mr Nicholas John Barnes
|  | Mrs Sophie Caroline Seldon
|  | Mrs Maxine Anne Mabbott
|  | Mr Lee Robert Hazelwood
|  | Mr Gareth Steven Logsdon
| Company number | NI710682
| Registered office | Emerson House
|  | 14b Ballynahinch Road
|  | Carryduff
|  | Down
|  | BT8 8DN
| Business address | Emerson House
|  | 14b Ballynahinch Road
|  | Carryduff
|  | Down
|  | BT8 8DN

BW Ireland Ltd
Statement of financial position
31 March 2026

|  |  | 2026 |  |  |  | 2025 |  |
|  | Note | £ |  | £ |  | £ |  | £
Current assets |  |  |  |  |  |  |  |  |
Stocks |  |  | 217,653 |  |  |  | 249,462 |  |
Debtors |  | 4 | 107,474 |  |  |  | 102,589 |  |
Investments |  | 5 | 100 |  |  |  | 100 |  |
Cash at bank and in hand |  |  | 2,749 |  |  |  | 984 |  |
|  |  | _______ |  |  |  | _______ |  |
|  |  | 327,976 |  |  |  | 353,135 |  |
Creditors: amounts falling due |  |  |  |  |  |  |  |  |
within one year |  | 6 | ( 334,746) |  |  |  | ( 379,966) |  |
|  |  | _______ |  |  |  | _______ |  |
Net current liabilities |  |  |  |  | ( 6,770) |  |  |  | ( 26,831)
|  |  |  |  | _______ |  |  |  | _______
Total assets less current liabilities |  |  |  |  | ( 6,770) |  |  |  | ( 26,831)
|  |  |  |  | _______ |  |  |  | _______
Net liabilities |  |  |  |  | ( 6,770) |  |  |  | ( 26,831)
|  |  |  |  | _______ |  |  |  | _______
Capital and reserves |  |  |  |  |  |  |  |  |
Called up share capital |  |  |  |  | 100 |  |  |  | 100
Profit and loss account |  |  |  |  | ( 6,870) |  |  |  | ( 26,931)
|  |  |  |  | _______ |  |  |  | _______
Shareholders deficit |  |  |  |  | ( 6,770) |  |  |  | ( 26,831)
|  |  |  |  | _______ |  |  |  | _______

For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 19 August 2026 , and are signed on behalf of the board by:
Mrs Sophie Caroline Seldon
Director
Company registration number: NI710682
BW Ireland Ltd
Notes to the financial statements
Year ended 31 March 2026
1. General information
The company is a private company limited by shares, registered in Northern Ireland. The address of the registered office is BW Ireland Ltd, Emerson House, 14b Ballynahinch Road, Carryduff, Down, BT8 8DN.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Debtors

|  |  | 2026 | 2025
|  |  | £ | £
| Trade debtors |  | 54,752 | 55,195
| Other debtors |  | 52,722 | 47,394
|  |  | _______ | _______
|  |  | 107,474 | 102,589
|  |  | _______ | _______

5. Investments

|  |  | 2026 | 2025
|  |  | £ | £
| Investment from Stanilod |  | 100 | 100
|  |  | _______ | _______

6. Creditors: amounts falling due within one year

|  |  | 2026 | 2025
|  |  | £ | £
| Bank loans and overdrafts |  | 34,493 | -
| Trade creditors |  | 265,195 | 373,991
| Amounts owed to group undertakings and undertakings in which the company has a participating interest |  | 30,000 | -
| Other creditors |  | 5,058 | 5,975
|  |  | _______ | _______
|  |  | 334,746 | 379,966
|  |  | _______ | _______

7. Related party transactions
During the year the company entered into the following transactions with related parties:

|  | Transaction value |  | Balance owed by/(owed to) |
|  | 2026 | 2025 | 2026 | 2025
|  | £ | £ | £ | £
| The Chilli Doctor sro | 26,490 | 3,510 | 30,000 | 3,510
| Barnes Williams UK | (102,506) | 346,144 | 243,638 | 346,144
| Stanilod Group Ltd | (2,726) | 9,139 | - | 2,726
| BW UK & Far East | (6,288) | 24,641 | - | 6,288
|  | _______ | _______ | _______ | _______

Stanilod Group Ltd is the parent company for three different entities (Barnes Williams UK & Far East Asia, BW Ireland Ltd , and the Chilli Doctor Ltd).
Stanilod Group Ltd has 100% shareholding in Barnes Williams Uk & Far East Asia and BW Ireland Ltd.
Stanilod Group Ltd has a 75% shareholding in The Chilli Doctor Ltd, The Chilli Doctor Ltd has a 100% shareholding in Chilli Doctor sro.
Nicholas John Blissard Barnes is a director and majority shareholder of Stanilod Group Limited. He is also director of Barnes Williams (UK & Far East) Limited, BW Catering Products Limited, The Chilli Doctor Limited and BW Ireland LTD.
Transactions during the year from Stanilod Group Ltd pertain to general costs of goods sold, storage costs and freight & delivery costs.
Transactions during the year from Barnes Williams UK relate to funds introduced into BW Ireland Ltd in the year.
Transactions during the year from BW UK & Far East pertain to costs of goods sold & freight costs.
Maxine Anne Mabbott is a director of Stanilod Group Ltd, BW Ireland Ltd and Barnes Williams (UK & Far East) Ltd.
Transactions during the year relate to general costs of goods sold, storage and freight & delivery costs.